scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051661783 |
P356 | DOI | 10.1038/SJ.CGT.7700492 |
P698 | PubMed publication ID | 12224020 |
P5875 | ResearchGate publication ID | 11165593 |
P50 | author | Meenhard Herlyn | Q16732421 |
Richelle Takemoto | Q125342064 | ||
P2093 | author name string | Edward R Sauter | |
Samuel Litwin | |||
P2860 | cites work | WAF1, a potential mediator of p53 tumor suppression | Q27861121 |
Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 | Q28199142 | ||
Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
D-type cyclin-dependent kinase activity in mammalian cells | Q29614966 | ||
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control | Q29616465 | ||
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma | Q34982679 | ||
Function of a human cyclin gene as an oncogene | Q34994859 | ||
Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector | Q35068584 | ||
The retinoblastoma protein as a transcriptional repressor | Q35632949 | ||
Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin | Q35746395 | ||
Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum | Q37377431 | ||
Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53. | Q40877042 | ||
Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression | Q41213792 | ||
Expression of the alpha 2-subunit of laminin correlates with increased cell adhesion and metastatic propensity | Q41432902 | ||
Overexpression and mutations of p53 in metastatic malignant melanomas | Q42519944 | ||
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides | Q42818480 | ||
Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model | Q44579002 | ||
Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer | Q45886523 | ||
Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation | Q71560882 | ||
Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus | Q73702910 | ||
P433 | issue | 10 | |
P304 | page(s) | 807-812 | |
P577 | publication date | 2002-10-01 | |
P1433 | published in | Cancer Gene Therapy | Q15763088 |
P1476 | title | p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma | |
P478 | volume | 9 |
Q38348323 | A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. |
Q35146577 | Apoptosis and melanoma chemoresistance |
Q35710194 | Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression |
Q40539899 | Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells |
Q37418155 | Cyclin D2 protein stability is regulated in pancreatic beta-cells |
Q35838744 | New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers |
Q34389406 | Retracted: The Effect of miR-338-3p on HBx Deletion-Mutant (HBx-d382) Mediated Liver-Cell Proliferation through CyclinD1 Regulation |
Q40214713 | Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression. |
Q34180283 | Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol |
Q37590569 | Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16. |
Q37081504 | The use of p53 as a tool for human cancer therapy |
Q46773108 | p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA. |
Search more.